Clinical Trial Update: An Open-Label Pilot Study of VTX2735 in Recurrent Pericarditis [Phase 2]

View source ↗

Summary

This clinical trial update notes that an open-label Phase 2 pilot study of VTX2735 for recurrent pericarditis is currently recruiting, sponsored by Zomagen Bios…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pericarditis

Drugs mentioned

• VTX2735

Snippet

Sponsor: Zomagen Biosciences Ltd. | Conditions: Recurrent Pericarditis | Phase 2 | Status: RECRUITING